AKT1 and Insulin resistance: Mitochondrial dysfunction and subsequent excess ROS production promote insulin resistance by activating c-Jun N-terminal kinases (JNK) and NLR family pyrin domain containing 3 (NLRP3) inflammasome which leads to the deactivation of the IRS1/PI3K/AKT pathway and the progression of insulin resistance [21].